相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Development of a maturing t-cell-mediated immune response in patients with idiopathic parkinson's disease receiving r-metHuGDNF via continuous intraputaminal infusion
Suzanna M. Tatarewicz et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2007)
GDNF in Parkinson disease: An object lesson in the tyranny of type II
Michael Hutchinson et al.
JOURNAL OF NEUROSCIENCE METHODS (2007)
GDNF in Parkinson's disease: The perils of post-hoc power
James Matcham et al.
JOURNAL OF NEUROSCIENCE METHODS (2007)
Novel neurotrophic factor CDNF protects and rescues midbrain dopamine neurons in vivo
Pivi Lindholm et al.
NATURE (2007)
Convective delivery of glial cell line-derived neurotrophic factor in the human putamen
Paul F. Morrison et al.
JOURNAL OF NEUROSURGERY (2007)
Chemical modification of therapeutic drugs or drug vector systems to achieve targeted therapy: Looking for the grail
L. Juillerat-Jeanneret et al.
MEDICINAL RESEARCH REVIEWS (2007)
Striatal delivery of CERE-120, an AAV2 vector encoding human neurturin, enhances activity of the dopaminergic nigrostriatal system in aged monkeys
Christopher D. Herzog et al.
MOVEMENT DISORDERS (2007)
Intrastriatal administration of erythropoietin protects dopaminergic neurons and improves neurobehavioral outcome in a rat model of Parkinson's disease
Y.-Q. Xue et al.
NEUROSCIENCE (2007)
Unilateral intraputamenal glial cell line-derived neurotrophic factor in patients with Parkinson disease: response to 1 year of treatment and 1 year of withdrawal
John T. Slevin et al.
JOURNAL OF NEUROSURGERY (2007)
GDNF family receptor complexes are emerging drug targets
Maxim M. Bespalov et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2007)
Immunohistochemical distribution of NGF, BDNF, NT-3, and NT-4 in adult rhesus monkey brains
Hong-Tian Zhang et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2007)
Six-month continuous intraputamenal infusion toxicity study of recombinant methionyl human glial cell line-derived neurotrophic factor (r-metHuGDNF) in rhesus monkeys
David N. Hovland et al.
TOXICOLOGIC PATHOLOGY (2007)
Oncoprotein Akt/PKB induces trophic effects in murine models of Parkinson's disease
Vincent Ries et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Point source concentration of GDNF may explain failure of phase II clinical trial
Michael F. Salvatore et al.
EXPERIMENTAL NEUROLOGY (2006)
Delivery of neurturin by AAV2 (CERE-120)-mediated gene transfer provides structural and functional neuroprotection and neurorestoration in MPTP-treated monkeys
Jeffrey H. Kordower et al.
ANNALS OF NEUROLOGY (2006)
HSV-mediated delivery of erythropoietin restores dopaminergic function in MPTP-treated mice
Veljko Puskovic et al.
MOLECULAR THERAPY (2006)
Autoregulation of glial cell line-derived neurotrophic factor expression: implications for the long-lasting actions of the anti-addiction drug, Ibogaine
Dao-Yao He et al.
FASEB JOURNAL (2006)
Functional mimetics of neurotrophins and their receptors
J. Peleshok et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2006)
Gene expression patterns for GDNF and its receptors in the human putamen affected by Parkinson's disease:: A real-time PCR study
Cristina M. Backman et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2006)
Histological effects of intraputaminal infusion of glial cell line-derived neurotrophic factor in Parkinson disease model macaque monkeys
Y Oiwa et al.
NEUROLOGIA MEDICO-CHIRURGICA (2006)
The Parkinson's complex: Parkinsonism is just the tip of the iceberg
JW Langston
ANNALS OF NEUROLOGY (2006)
Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease (vol 9, pg 589, 2003)
SS Gill et al.
NATURE MEDICINE (2006)
MRI volumetric and intensity analysis of the cerebellum in Parkinson's disease patients infused with glial-derived neurotrophic factor (GDNF)
H Chebrolu et al.
EXPERIMENTAL NEUROLOGY (2006)
Human neural progenitors deliver glial cell line-derived neurotrophic factor to parkinsonian rodents and aged primates
S Behrstock et al.
GENE THERAPY (2006)
Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease
AE Lang et al.
ANNALS OF NEUROLOGY (2006)
Convection-enhanced delivery of adeno-associated virus Type 2 (AAV2) into the striatum and transport of AAV2 within monkey brain
P Hadaczek et al.
HUMAN GENE THERAPY (2006)
Crossroads in GDNF therapy for Parkinson's disease
TB Sherer et al.
MOVEMENT DISORDERS (2006)
BDNF genetic variants are associated with onset age of familial Parkinson disease:: GenePD study
S Karamohamed et al.
NEUROLOGY (2005)
Antidepressant action: to the nucleus and beyond
JE Malberg et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2005)
An epidemiological study of motor neuron disease in Hong Kong
GCY Fong et al.
AMYOTROPHIC LATERAL SCLEROSIS (2005)
Glial cell line-derived neurotrophic factor induces neuronal sprouting in human brain
S Love et al.
NATURE MEDICINE (2005)
Brain-derived neurotrophic factor is required for the establishment of the proper number of dopaminergic neurons in the substantia nigra pars compacta
ZC Baquet et al.
JOURNAL OF NEUROSCIENCE (2005)
Immune responses to adeno-associated virus vectors
AK Zaiss et al.
CURRENT GENE THERAPY (2005)
Autonomic dysfunction in ALS: A preliminary study on the effects of intrathecal BDNF
M Beck et al.
AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS (2005)
Anatomical basis of glial cell line-derived neurotrophic factor expression in the striatum and related basal ganglia during postnatal development of the rat
TF Oo et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2005)
Improvement of bilateral motor functions in patients with Parkinson disease through the unilateral intraputaminal infusion of glial cell line-derived neurotrophic factor
JT Slevin et al.
JOURNAL OF NEUROSURGERY (2005)
Intraputamenal infusion of glial cell line-derived neurotrophic factor in PD: A two-year outcome study
NK Patel et al.
ANNALS OF NEUROLOGY (2005)
Continuous low-level glial cell line-derived neurotrophic factor delivery using recombinant adeno-associated viral vectors provides neuroprotection and induces behavioral recovery in a primate model of Parkinson's disease
A Eslamboli et al.
JOURNAL OF NEUROSCIENCE (2005)
Effects of perceived treatment on quality of life and medical outcomes in a double-blind placebo surgery trial
C McRae et al.
ARCHIVES OF GENERAL PSYCHIATRY (2004)
Localized striatal delivery of GDNF as a treatment for Parkinson disease
D Kirik et al.
NATURE NEUROSCIENCE (2004)
Pure red-cell aplasia and epoetin therapy
CL Bennett et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Morphological and functional effects of PACAP in 6-hydroxydopamine-induced lesion of the substantia nigra in rats
D Reglodi et al.
REGULATORY PEPTIDES (2004)
N-terminal tripeptide of IGF-I improves functional deficits after 6-OHDA lesion in rats
R Krishnamurthi et al.
NEUROREPORT (2004)
The timecourse of induction of brain-derived neurotrophic factor mRNA and protein in the rat hippocampus following voluntary exercise
PA Adlard et al.
NEUROSCIENCE LETTERS (2004)
Intraputamenal infusion of GDNF in aged rhesus monkeys: Distribution and dopaminergic effects
Y Ai et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2003)
Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease
SS Gill et al.
NATURE MEDICINE (2003)
MANF - A new mesencephalic, astrocyte-derived neurotrophic factor with selectivity for dopaminergic neurons
PS Petrova et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2003)
Protective action of recombinant neurturin on dopaminergic neurons in substantia nigra in a Rhesus monkey model of Parkinson's disease
HJ Li et al.
NEUROLOGICAL RESEARCH (2003)
Neuroprotective effects of prior limb use in 6-hydroxydopamine-treated rats: possible role of GDNF
AD Cohen et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD
JG Nutt et al.
NEUROLOGY (2003)
XIB4035, a novel nonpeptidyl small molecule agonist for GFR alpha-1
K Tokugawa et al.
NEUROCHEMISTRY INTERNATIONAL (2003)
Chronic, controlled GDNF infusion promotes structural and functional recovery in advanced parkinsonian monkeys
R Grondin et al.
BRAIN (2002)
Aberrant sprouting and downregulation of tyrosine hydroxylase in lesioned nigrostriatal dopamine neurons induced by long-lasting overexpression of glial cell line derived neurotrophic factor in the striatum by lentiviral gene transfer
B Georgievska et al.
EXPERIMENTAL NEUROLOGY (2002)
Dopaminergic neuroprotection and regeneration by neurturin assessed by using behavioral, biochemical and histochemical measurements in a model of progressive Parkinson's disease
Y Oiwa et al.
BRAIN RESEARCH (2002)
Effects of fibroblast growth factor and glial-derived neurotrophic factor on akinesia, F-DOPA uptake and dopamine cells in parkinsonian primates
A Fontan et al.
PARKINSONISM & RELATED DISORDERS (2002)
Location, location, location: a spatial view of neurotrophin signal transduction
HM Heerssen et al.
TRENDS IN NEUROSCIENCES (2002)
Targeting neurotherapeutic agents through the blood-brain barrier
WM Pardridge
ARCHIVES OF NEUROLOGY (2002)
GDNF acutely modulates excitability and A-type K+ channels in midbrain dopaminergic neurons
F Yang et al.
NATURE NEUROSCIENCE (2001)
Neurotrophic factor structures reveal clues to evolution, binding, specificity, and receptor activation
MJ Butte
CELLULAR AND MOLECULAR LIFE SCIENCES (2001)
Delayed infusion of GDNF promotes recovery of motor function in the partial lesion model of Parkinson's disease
D Kirik et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2001)
Activity-dependent transfer of brain-derived neurotrophic factor to postsynaptic neurons
K Kohara et al.
SCIENCE (2001)
Glial cell line-derived neurotrophic factor in the substantia nigra from control and parkinsonian brains
M Mogi et al.
NEUROSCIENCE LETTERS (2001)
Fibroblast growth factor-2-producing fibroblasts protect the nigrostriatal dopaminergic system from 6-hydroxydopamine
C Shults et al.
BRAIN RESEARCH (2000)
Preservation of a functional nigrostriatal dopamine pathway by GDNF in the intrastriatal 6-OHDA lesion model depends on the site of administration of the trophic factor
D Kirik et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2000)
Reduced BDNF mRNA expression in the Parkinson's disease substantia nigra
DW Howells et al.
EXPERIMENTAL NEUROLOGY (2000)
Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease
JH Kordower et al.
SCIENCE (2000)
N-terminal tripeptide of IGF-1 (GPE) prevents the loss of TH positive neurons after 6-OHDA induced nigral lesion in rats
J Guan et al.
BRAIN RESEARCH (2000)
分享论文
